{"name":"REGENXBIO Inc.","slug":"regenxbio-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE5UU0FaYVd2c0JHUng1UDJyLVNORzhYTURjY2wtMkRWbVlhSTFDR1JZZEdCMUM3R3dreFZhNGs4RmpaZkpSTWgtSjZkZjE2YzI0Qm9sX0ZjeW9GVjJEeFhjZVBVNUnSAWpBVV95cUxOdzlycHV3d3hpeUhNYTg4b1JrNE5lVERhMUQwcHBYcFlqRVJGMGg4VVVSR2ZLN05VTGlwWWZzMkRsa0h2c2ctSTVpc2NKMlplSmlFTVZHaGIzaXJfUHBjdWhWZ0JST2pub0hR?oc=5","date":"2026-03-20","type":"pipeline","source":"Bitget","summary":"According to a document submitted to the U.S. Securities and Exchange Commission, biotechnology company Regenxbio Inc has confirmed that it will continue, under its existing sublicensing agreement wit","headline":"According to a document submitted to the U.S. Securities and Exchange Commission, biotechnology company Regenxbio Inc ha","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxQUExUS005MENDWHRmeFY4Qk8yTXRIdkJSTzZDT1RRY0p6SWdRYndKRFRwN2hnZjBXa2RTTWxoY0tfSHc0eExYVmVXVTV1c2FFZnptOXZLcTZuQ1J3WUFLeVFVUXM1VTVWRjF6RjhnaDVFRUVBUHJSS3hacW9VY3VCQU5MTV9SR3BNOW12NnNLN19kMzBfSk9yN051STgwOG5hcmFkTlhSNzAwXzZuM3pZa1JUdnpqVGtpR1FoMkVYaFBtU3h0NjJjb1FWY0I4ZzFQeHVIM3RzWVYwMlRzQ09XVmExR3J1SVFHSzAwNjQ0OS1aVVk5SHQ5Mw?oc=5","date":"2026-03-13","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Are Neutral on These Healthcare Stocks: RegenXBio (RGNX), Roche Holding AG (RHHVF) - The Globe and Mail","headline":"Analysts Are Neutral on These Healthcare Stocks: RegenXBio (RGNX), Roche Holding AG (RHHVF)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOeXZ4SWhvY1d1ZFFtZHViZHdFN2V5alpUV1pOeDJWR1E5UmttM0tYei1EVmtWb3UtbE5uZy1mdUV3dG03bEIzaU9ndVljWk5qdnAyZ1pZeXhqcjRiYVoxeUkzLUpGa3o5dG1tUlRjYUt0STJ2ZXhJTFpoS1lwanJFYXYyYUVXaE1WZlN2MURXZkVHYU9jamlodg?oc=5","date":"2026-03-12","type":"pipeline","source":"BioWorld News","summary":"MDA: Vinay away, AA in play for Regenxbio gene therapy? - BioWorld News","headline":"MDA: Vinay away, AA in play for Regenxbio gene therapy?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPRDMtc1ZNcDJFd3E1dU4xalkwMUlpaFNSQ2J5aS1Lb2Fxa1RIaVpFRUhYNDNXcWNQbDRwbnF0RmxPV2FnUzJVOGxrc3hXSUtzLWEtQVRQLXpxcnFCclRqMUNKYVM3T2RMQUF2ODc1ZnFaUFVyQXBJVVpNa3VRUE5LNmppSFFNUXhhUXFIcHpfWHFfbjhzU3ZDX0dpVmI?oc=5","date":"2026-02-10","type":"regulatory","source":"BioPharma Dive","summary":"FDA rejects Regenxbio treatment in another blow to gene therapy - BioPharma Dive","headline":"FDA rejects Regenxbio treatment in another blow to gene therapy","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQOERkNXNGX05jeWdQNWFrTFpCcW0yWDFKUlZLaFFRX2J0UHpxRTk4SVdaOUdlOS11WUF3Q2xHOEloU2JvUUFvUGhJb283TmV2Tm9SRkdpRTNNSzRpdVNZU3E4MG5IdDl5Zk9USTR3X1JFZTlXTFlBR2NKZVBvM28yVjcwOVZZdjBtTDhZMENkUmVldm9vclAxNFg4UmQ0WWdTWnFLR3NzVGRuZlRVTmNYVjlkdW1LcHg3MF94V0kzdWpXQQ?oc=5","date":"2026-02-09","type":"regulatory","source":"Reuters","summary":"US FDA declines to approve Regenxbio's gene therapy for rare disease - Reuters","headline":"US FDA declines to approve Regenxbio's gene therapy for rare disease","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPRHR1bHlZQzhrT2x5LVBJT2NPWkdUQWctOTI4eUNkQVR4UVhDOW9wNDlGRGZlNlRTWktqTTdpWWJwWWEwbmlabm5qQVRfVVF3N1A5T0wwX0UtZnM3QjhWbnVWQ0N5VFVjRTZZRTViTjdfR2N4aGg2aG9DT00waGRjVW1xMVpUTGdseEtRM1RtcEg?oc=5","date":"2026-02-02","type":"regulatory","source":"BioSpace","summary":"FDA Action Alert: Sanofi/Regeneron, Merck, REGENXBIO and More - BioSpace","headline":"FDA Action Alert: Sanofi/Regeneron, Merck, REGENXBIO and More","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPbWxTYkdOR1psdndyYnU5bTZsYWdXUTdPZURZNkUxaF83THZLYXQ5a1NjLXpCcmNaOFYwTjRZelJHaDFyVEExSlFRVWs1TTBoWEZUeEY5UV9SYW5PUGE3QnJMclptWFB2YnFVeXdYOTJhajU4Ukg3QWdvWTkzdTlnVFZ5WFBfeE5uYzZrbVh5TzZDcDdCeGs3aE5tZ1A4UQ?oc=5","date":"2026-01-28","type":"regulatory","source":"BioPharma Dive","summary":"Regenxbio gene therapy trials suspended by FDA over safety worries - BioPharma Dive","headline":"Regenxbio gene therapy trials suspended by FDA over safety worries","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9pbnhjZjI0b3hTY2h3VFl4TmNKejJtem9WSHFLQzZZQUxUaTRSU0hZNzJEcjYtYWZ6cnpGcThweXQ1U2VONUVOT2xNQk5jSHVqTENOVzBiX195bUJnS3RBd24zZ3l4YTVFYWw2ZGNBTkVwSHE3ZUdUSNIBVkFVX3lxTE9XMkZSRUF4Q2hxOGFocHBSVGIxckZpOHRtMFlQVTdkRDZMd1VVdUpxNksySW1vT3hmRENOX2tyWlFFVWZTeGM2Qk13NnpoekVVeHpuZ2l3?oc=5","date":"2026-01-02","type":"patent","source":"Law360","summary":"Patent Cases To Watch In 2026 - Law360","headline":"Patent Cases To Watch In 2026 - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNbG9xOEx5Y3dHZnFzd3FwVkhfdndhQUl2aktGaEYwd01JUW5STEJxMkY0NXhoZGd1NVRvZGNRZmM4TThNN2laVm5BRDBtVUxIakZwR2dLMlk0ZHp3TzZrQnlTM0c1TkVWeDJlY3hKd3dsamw2aFBrdFE2V09Cd2JxZ0V4eTU2eWZnVkQxRWJYWFZHblUzQmlhUkdwNEM2NGQzMm1RMDVnNnRZbVZuaktWM3ZhRzNpNGZGbkJ4WkplcTU?oc=5","date":"2025-12-31","type":"regulatory","source":"The Pharma Letter","summary":"Prospects for Regenxbio’s clemidsogene lanparvovec approval in Hunter syndrome - The Pharma Letter","headline":"Prospects for Regenxbio’s clemidsogene lanparvovec approval in Hunter syndrome","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNSkVJS3F6SXVyZDVKWlBObXRMMzE1S2dHUmtDMFdQX3dKRFdYV2RWOG1yTlA4V0JSRjRzUHkyT3Bvb3hSbnVFQnJMcVRXUFUxMmtEekZneTVGT3hYVzNQX1lvVTRiank1Yl8xWEVpMl9CcDdfRHp4UlJucE1mcUlycV92N2doc0JjLWoxTW80ZEc?oc=5","date":"2025-08-25","type":"regulatory","source":"CGTLive®","summary":"FDA Bumps Back PDUFA for REGENXBIO's MPS II Gene Therapy RGX-121 - CGTLive®","headline":"FDA Bumps Back PDUFA for REGENXBIO's MPS II Gene Therapy RGX-121 - CGTLive®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNQkNPcDNUc3owanRYdVpJcHF3VzhKNmZpeG9EcE5pVEZJLS0tTW9kVXoxV3JlT3Z3OExZckFyWDVnLW5JV0czbGh4V2ZieHlqaVBMbFV3VlJwOVY3VlpVZm5VQ2ZWanBVQlEtVmpaaE1mOUdtZk9mb194TVdfaWhaWGM1V2JuSnhyYjFaQXhLZTJVV1AtUFVkN1NOSEJWVHNRZ0J6dms4aw?oc=5","date":"2025-08-19","type":"regulatory","source":"Fierce Biotech","summary":"FDA pushes back PDUFA date for Regenxbio's Hunter syndrome gene therapy - Fierce Biotech","headline":"FDA pushes back PDUFA date for Regenxbio's Hunter syndrome gene therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNY0VYekw3Y1JMTzlFenBUb2pZR1pfRG9fVThNZkRWcVNMbHNXbDlxRzZnaFJIYjVFd3NzUjRUT0VLb1pnNU9najRKSk84M240Z3JwS0dzekhfTWpSZGhlb2R3QS1LQk9ZTG1Pb3NlUnFtQU5Uc3JyUGVSamgwenIzOEdRQnlZMFhxZ0ZrLW9ad3ViQXZZc1UxYVdXTzNHX2c?oc=5","date":"2025-05-15","type":"regulatory","source":"CGTLive®","summary":"REGENXBIO’s BLA for MPS II Gene Therapy RGX-121 Accepted for Priority Review by the FDA - CGTLive®","headline":"REGENXBIO’s BLA for MPS II Gene Therapy RGX-121 Accepted for Priority Review by the FDA - CGTLive®","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}